These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 31568987)
1. Pantoprazole pretreatment elevates sensitivity to vincristine in drug-resistant oral epidermoid carcinoma in vitro and in vivo. Lu ZN; Shi ZY; Dang YF; Cheng YN; Guan YH; Hao ZJ; Tian B; He HW; Guo XL Biomed Pharmacother; 2019 Dec; 120():109478. PubMed ID: 31568987 [TBL] [Abstract][Full Text] [Related]
2. Rosiglitazone elevates sensitization of drug-resistant oral epidermoid carcinoma cells to vincristine by G2/M-phase arrest, independent of PPAR-γ pathway. Wang HY; Zhang Y; Zhou Y; Lu YY; Wang WF; Xin M; Guo XL Biomed Pharmacother; 2016 Oct; 83():349-361. PubMed ID: 27416556 [TBL] [Abstract][Full Text] [Related]
3. Pyramidatine (Z88) Sensitizes Vincristine-Resistant Human Oral Cancer (KB/VCR) Cells to Chemotherapeutic Agents by Inhibition of P-glycoprotein. Liu Z; Zhu H; Qu S; Tang L; Cao L; Yu W; Yang X; Jiang S; Zhu D; Tan C; Yu L Anticancer Agents Med Chem; 2018; 18(2):286-294. PubMed ID: 28782465 [TBL] [Abstract][Full Text] [Related]
4. Reversal effects of pantoprazole on multidrug resistance in human gastric adenocarcinoma cells by down-regulating the V-ATPases/mTOR/HIF-1α/P-gp and MRP1 signaling pathway in vitro and in vivo. Chen M; Huang SL; Zhang XQ; Zhang B; Zhu H; Yang VW; Zou XP J Cell Biochem; 2012 Jul; 113(7):2474-87. PubMed ID: 22396185 [TBL] [Abstract][Full Text] [Related]
5. Quercetin inhibits proliferation and drug resistance in KB/VCR oral cancer cells and enhances its sensitivity to vincristine. Yuan Z; Wang H; Hu Z; Huang Y; Yao F; Sun S; Wu B Nutr Cancer; 2015; 67(1):126-36. PubMed ID: 25514492 [TBL] [Abstract][Full Text] [Related]
6. Riccardin D-26, a synthesized macrocyclic bisbibenzyl compound, inhibits human oral squamous carcinoma cells KB and KB/VCR: In vitro and in vivo studies. Yue B; Zhao CR; Xu HM; Li YY; Cheng YN; Ke HN; Yuan Y; Wang RQ; Shi YQ; Lou HX; Qu XJ Biochim Biophys Acta; 2013 Jan; 1830(1):2194-203. PubMed ID: 23085067 [TBL] [Abstract][Full Text] [Related]
7. Hyperin Enhances the Sensitivity of HCT8/VCR Colon Cancer Cell Line to Vincristine by Down-Regulating P-Glycoprotein. Wang LM; Zhang MY; Zhu QS; Lu CF; Bai X Clin Lab; 2018 Mar; 64(3):269-275. PubMed ID: 29739100 [TBL] [Abstract][Full Text] [Related]
8. Co-treatment With HIV Protease Inhibitor Nelfinavir Greatly Increases Late-phase Apoptosis of Drug-resistant KBV20C Cancer Cells Independently of P-Glycoprotein Inhibition. Kim JY; Park YJ; Lee BM; Yoon S Anticancer Res; 2019 Jul; 39(7):3757-3765. PubMed ID: 31262902 [TBL] [Abstract][Full Text] [Related]
9. DHPAC, a novel synthetic microtubule destabilizing agent, possess high anti-tumor activity in vincristine-resistant oral epidermoid carcinoma in vitro and in vivo. Zhang Y; Gong FL; Lu ZN; Wang HY; Cheng YN; Liu ZP; Yu LG; Zhang HH; Guo XL Int J Biochem Cell Biol; 2017 Dec; 93():1-11. PubMed ID: 29074436 [TBL] [Abstract][Full Text] [Related]
10. Multidrug resistant P-glycoprotein positive L1210/VCR cells are also cross-resistant to cisplatin via a mechanism distinct from P-glycoprotein-mediated drug efflux activity. Gibalová L; Sedlák J; Labudová M; Barancík M; Reháková A; Breier A; Sulová Z Gen Physiol Biophys; 2009 Dec; 28(4):391-403. PubMed ID: 20097962 [TBL] [Abstract][Full Text] [Related]
11. Reversal of P-glycoprotein-mediated multidrug resistance in SGC7901/VCR cells by PPARgamma activation by troglitazone. Chen Q; Zhou J; Jiang C; Chen J J Huazhong Univ Sci Technolog Med Sci; 2010 Jun; 30(3):326-31. PubMed ID: 20556576 [TBL] [Abstract][Full Text] [Related]
12. Secreted amphiregulin promotes vincristine resistance in oral squamous cell carcinoma. Hsieh MJ; Chen YH; Lee IN; Huang C; Ku YJ; Chen JC Int J Oncol; 2019 Oct; 55(4):949-959. PubMed ID: 31485602 [TBL] [Abstract][Full Text] [Related]
13. Epigallocatechin-3-gallate sensitises multidrug-resistant oral carcinoma xenografts to vincristine sulfate. Chen L; Guo X; Hu Y; Li L; Liang G; Zhang G FEBS Open Bio; 2020 Jul; 10(7):1403-1413. PubMed ID: 32475087 [TBL] [Abstract][Full Text] [Related]
14. The COX-2 inhibitor Celecoxib enhances the sensitivity of KB/VCR oral cancer cell lines to Vincristine by down-regulating P-glycoprotein expression and function. Yan YX; Li WZ; Huang YQ; Liao WX Prostaglandins Other Lipid Mediat; 2012 Jan; 97(1-2):29-35. PubMed ID: 21835258 [TBL] [Abstract][Full Text] [Related]
16. P-gp Inhibition by the Anti-psychotic Drug Pimozide Increases Apoptosis, as well as Expression of pRb and pH2AX in Highly Drug-resistant KBV20C Cells. Kim JY; Park Y; Lee BM; Kim HS; Yoon S Anticancer Res; 2018 Oct; 38(10):5685-5692. PubMed ID: 30275188 [TBL] [Abstract][Full Text] [Related]
17. P-gp Inhibition by XL019, a JAK2 Inhibitor, Increases Apoptosis of Vincristine-treated Resistant KBV20C Cells with Increased p21 and pH2AX Expression. Cheon JH; Kim JY; Lee BM; Kim HS; Yoon S Anticancer Res; 2017 Dec; 37(12):6761-6769. PubMed ID: 29187454 [TBL] [Abstract][Full Text] [Related]
18. Zerumbone targets the CXCR4-RhoA and PI3K-mTOR signaling axis to reduce motility and proliferation of oral cancer cells. Zainal NS; Gan CP; Lau BF; Yee PS; Tiong KH; Abdul Rahman ZA; Patel V; Cheong SC Phytomedicine; 2018 Jan; 39():33-41. PubMed ID: 29433681 [TBL] [Abstract][Full Text] [Related]